WSG WOMEN´S HEALTHCARE STUDY GROUP   Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2017
NCT03220178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

WSG WOMEN´S HEALTHCARE STUDY GROUP